Announcements
- Prestige Consumer Healthcare Inc. Reports Fiscal Year 2024 Results
- Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results
- Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag
- Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results
- Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene
- Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results
- Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene
- Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene
- Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results
- Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Second Quarter Earnings Results
More ▼
Key statistics
On Friday, Prestige Consumer Healthcare Inc (PBH:DEU) closed at 57.50, 10.58% above the 52 week low of 52.00 set on Nov 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 57.50 |
---|---|
High | 57.50 |
Low | 57.50 |
Bid | 59.50 |
Offer | 60.00 |
Previous close | 57.50 |
Average volume | 0.00 |
---|---|
Shares outstanding | 49.92m |
Free float | 49.25m |
P/E (TTM) | 15.41 |
Market cap | 3.21bn USD |
EPS (TTM) | 4.17 USD |
Data delayed at least 15 minutes, as of May 31 2024.
More ▼